{"date":"2026-10-05","count":7,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6847-2026-10-05-1750-5pdpa9","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-10-05","time":"17:50:44","subject":"公告本公司115年第一次現金增資延長特定人繳款期限","clause":"第44款","fact_date":"2026-10-05","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-10-05 17:50，「公告本公司115年第一次現金增資延長特定人繳款期限」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-10-05-1750-1yjpt51","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-10-05","time":"17:50:01","subject":"本公司有價證券於集中交易市場達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解","clause":"第53款","fact_date":"2026-10-05","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-10-05 17:50，「本公司有價證券於集中交易市場達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-10-05-1643-sqgrt0","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-10-05","time":"16:43:37","subject":"公告本公司法人董事代表人異動","clause":"第6款","fact_date":"2026-10-05","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-10-05 16:43，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-10-05-1632-b6vs57","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-10-05","time":"16:32:35","subject":"公告本公司國內第一次有擔保轉換公司債(簡稱：金萬林一，代碼：66451)於115年12月4日發行屆滿2年，債券持有人得行使賣回權相關事宜","clause":"第51款","fact_date":"2026-10-05","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-10-05 16:32，「公告本公司國內第一次有擔保轉換公司債(簡稱：金萬林一，代碼：66451)於115年12月4日發行屆滿2年，債券持有人得行」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-10-05-1631-18j8748","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-10-05","time":"16:31:05","subject":"公告本公司董事長訂定民國115年第二季除息基準日等相關事宜","clause":"第14款","fact_date":"2026-10-05","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-10-05 16:31，「公告本公司董事長訂定民國115年第二季除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2026-10-05-1508-r17qz5","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2026-10-05","time":"15:08:03","subject":"調整本公司111年度現金增資之資金運用計畫項目","clause":"第16款","fact_date":"2026-08-05","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2026-10-05 15:08，「調整本公司111年度現金增資之資金運用計畫項目」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-10-05-1055-1fqkmsr","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-10-05","time":"10:55:03","subject":"澄清媒體報導","clause":"第26款","fact_date":"2026-10-05","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-10-05 10:55，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}